Premium
eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in C rohn's disease
Author(s) -
Pedersen N.,
Elkjaer M.,
Duricova D.,
Burisch J.,
Dobrzanski C.,
Andersen N. N.,
Jess T.,
Bendtsen F.,
Langholz E.,
Leotta S.,
Knudsen T.,
Thorsgaard N.,
Munkholm P.
Publication year - 2012
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12043
Subject(s) - infliximab , ehealth , medicine , disease , world wide web , health care , computer science , economics , economic growth
Infliximab (IFX) maintenance therapy for Crohn's disease (CD) is administered every 8 weeks, but inter-patient variation in optimal treatment intervals may exist.